LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease
Sign Up to like & getrecommendations! Published in 2021 at "Biomolecules"
DOI: 10.3390/biom11081101
Abstract: Parkinson’s Disease (PD) affects millions of people worldwide with no cure to halt the progress of the disease. Leucine-rich repeat kinase 2 (LRRK2) is the most common genetic cause of PD and, as such, LRRK2… read more here.
Keywords: strategies potential; disease; lrrk2 targeting; targeting strategies ... See more keywords